Neptune Wellness Solutions Inc. Stock Toronto S.E.
Equities
NEPT
CA64079L2049
Pharmaceuticals
Sales 2022 | 48.8M 35.47M | Sales 2023 | 52.62M 38.25M | Capitalization | 6.36M 4.62M |
---|---|---|---|---|---|
Net income 2022 | -75M -54.52M | Net income 2023 | -60M -43.61M | EV / Sales 2022 | 0.97 x |
Net Debt 2022 | 5.61M 4.08M | Net Debt 2023 | 23.3M 16.94M | EV / Sales 2023 | 0.56 x |
P/E ratio 2022 |
-0.5
x | P/E ratio 2023 |
-0.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.01% |
1st Jan change | Capi. | |
---|---|---|
+23.41% | 3.65B | |
+117.23% | 2.06B | |
+68.25% | 55.21M | |
+265.38% | 54.09M |